Estimation of "needs" and "probable uptake" for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study).

@article{Esparza2003EstimationO,
  title={Estimation of "needs" and "probable uptake" for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study).},
  author={Jos{\'e} Esparza and Marie-Louise Chang and Roy Widdus and Yvette Madrid and Neff Walker and Peter Denis Ghys},
  journal={Vaccine},
  year={2003},
  volume={21 17-18},
  pages={2032-41}
}
Once an effective HIV vaccine is discovered, a major challenge will be to ensure its world wide access. A preventive vaccine with low or moderate efficacy (30-50%) could be a valuable prevention tool, especially if targeted to populations at higher risk of HIV infection. High efficacy vaccines (80-90%) could be used in larger segments of the population. Estimated "needs" for future HIV vaccines were based on anticipated policies regarding target populations. Estimated "needs" were adjusted for… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Risk behaviour monitoring among injecting drugs users (IDUs) participating in the AIDSVAX B/E vaccine trial in Bangkok

  • S Migasena, S Vanichseni, F van Griensven, B Phonrat, J Keawkangwal, K Hiranrus
  • Proceedings of the Sixth Internationl Congress on…
  • 2001
Highly Influential
8 Excerpts

The VaxGen Study Team. HIV risk behaviour change in a phase-III HIV vaccine efficacy trial

  • B Bartholow, S Buchbinder, D McKirnan, V Goli, C Celum
  • AIDS Vaccine 2001, Philadelphia,
  • 2001
Highly Influential
8 Excerpts

AIDS. Resource need for HIV/AIDS

  • B Schwärtlander, J Stover, N Walker, L Bollinger, JP Gutierrez, W McGreevey
  • Science
  • 2001
1 Excerpt

Similar Papers

Loading similar papers…